SCHEMBL6628774

SCHEMBL6628774

Cc1cnccc1CCO

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TKT P29401 1/20 0.39
▸ SIRT3 Q9NTG7 1/20 0.37
▸ TDP1 Q9NUW8 1/20 0.37
▸ AOC1 P19801 6/20 0.36
▸ AOC3 Q16853 6/20 0.36
▸ NOTUM Q6P988 1/20 0.36
▸ LOXL2 Q9Y4K0 1/20 0.35
▸ TRPA1 O75762 1/20 0.34
▸ CYP2E1 P05181 2/20 0.33
▸ CYP2C8 P10632 2/20 0.33
▸ CYP2D6 P10635 2/20 0.33
▸ CYP2A6 P11509 2/20 0.33
▸ CYP2C9 P11712 2/20 0.33
▸ CYP2B6 P20813 2/20 0.33
▸ CYP2C19 P33261 2/20 0.33
▸ CYP11B1 P15538 1/20 0.33
▸ CYP11B2 P19099 1/20 0.33
▸ KDM4E B2RXH2 1/20 0.33
▸ ALDH1A1 P00352 1/20 0.33
▸ CYP1A2 P05177 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6631535 0.83 TKT (0.42) TKTSIRT3TDP1NOTUMCYP2E1
SCHEMBL1448227 0.83 — —
SCHEMBL873728 0.81 CYP2E1 (0.49) TDP1AOC1AOC3LOXL2TRPA1
SCHEMBL14945019 0.79 TAAR1 (0.52) SIRT3TDP1AOC1AOC3LOXL2
Hydrochloric Acid SCHEMBL28577547 0.78 AOC1 (0.42) TKTAOC1AOC3LOXL2CYP2E1
SCHEMBL21983945 0.78 TAAR1 (0.50) NOTUMTRPA1CYP11B1CYP11B2KDM4E
SCHEMBL18924363 0.78 TDP1 (0.43) TDP1AOC1AOC3CYP2E1CYP2C8
SCHEMBL23599089 0.77 NPSR1 (0.53) SIRT3TDP1NOTUM
SCHEMBL27290290 0.77 GPR119 (0.35) SIRT3TDP1AOC1AOC3NOTUM
SCHEMBL25669530 0.76 HTR6 (0.53) CYP2A6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024105364-A1 HETEROCYCLIC INHIBITORS OF CDC-LIKE KINASES CURADEV PHARMA LTD (GB) 2024-05-23 — — WO disclosed
EP-2736330-A1 COMPOUNDS AND METHODS Tempero Pharmaceuticals, Inc. (US) 2014-06-04 — — EP disclosed
WO-2013019682-A1 COMPOUNDS AND METHODS TEMPERO PHARMACEUTICALS, INC. (US) 2013-02-07 — — WO disclosed
EP-0974602-B1 Catalyst and process for hydrogenating olefinically unsaturated compound JSR CORP (JP) 2004-01-02 — — EP disclosed
US-6291596-B1 CONTACTING OLEFINICALLY UNSATURATED COMPOUND WITH HYDROGEN IN THE PRESENCE OF A HYDROGENATION CATALYST COMPRISING TITANIUM OR ZIRCONIUM OR HAFNIUM COMPOUND IN AN INERT, ORGANIC SOLVENT JSR CORPORATION (JP) 2001-09-18 — — US disclosed
EP-0974602-A1 Catalyst and process for hydrogenating olefinically unsaturated compound JSR Corporation (JP) 2000-01-26 — — EP disclosed
US-4242516-A Fluorinated amphoteric surfactants CIBA-GEIGY CORPORATION (US) 1980-12-30 — — US disclosed
US-4161590-A Fluorinated amphoteric and cationic surfactants CIBA-GEIGY CORPORATION (US) 1979-07-17 — — US disclosed
US-4161602-A Fluorinated amphoteric and cationic surfactants containing a pyridinium moiety CIBA-GEIGY CORPORATION (US) 1979-07-17 — — US disclosed
US-4069244-A THIO-CARBOXYLIC ACIDS CIBA-GEIGY CORPORATION (US) 1978-01-17 — — US disclosed
Send feedback